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ABSTRACT
Dialysis access monitoring may help decrease thrombosis-
related morbidity. We investigated the effect of time elapsed
since an access flow measurement on test accuracy of a
novel flow monitoring method called variable flow (VF)
Doppler. A retrospective review was conducted in 36
patients with prosthetic grafts for vascular access using
access thrombosis as the clinical endpoint. Receiver oper-
ator characteristic (ROC) curves and test sensitivity and
specificity were determined for various follow-up time
intervals. ROC analysis showed increasing test discrimin-
ation for shorter time intervals. Sensitivity and specificity
for a commonly used surveillance threshold (600 ml/min)
showed specificity that was little changed (88–93%) from
follow-up time intervals of 15 days to 6 months. However,
sensitivity was low (21%) at 6 months, increased to 50% at
2 months, 67% at 1 month, and 100% at 15 days (a single
event). Low access blood flow using VF Doppler predicts
near-term thrombosis. These data further imply that the
discriminative value of access flow monitoring appears to be
highly dependent on time from the flow measurement,
improving with shorter time intervals from the measure-
ment.
Dialysis access remains a major cause of morbidity
among dialysis patients and a frequent cause for
hospitalization (1,2). The National Kidney Foundation
Dialysis Outcomes Quality Initiative guidelines (NKF-
DOQI) as well as many researchers and clinicians have
advocated access surveillance as a means to improve
patient care and reduce access-related costs (3–5). Several
techniques have been developed for access surveillance.
These methods include duplex ultrasound techniques
(6–9), static and dynamic access pressure monitoring
(9–12), recirculation (13), and indicator dilution tech-
niques (14–18). A method that measures access blood
flow using a changing Doppler signal as a function of
blood flow rate in the access during dialysis without the
need for duplex imaging is also being evaluated (19–22).
An ideal access monitoring test would predict nearly
all patients who will develop thromboses (i.e., be
highly sensitive) without falsely predicting thrombosis
in those who will not develop thromboses (i.e., be
highly specific). Even though access blood flow rate
appears to predict progression of access stenoses and
allows for timely intervention to prevent thrombosis
(3,6–8,18), at least in some patient populations access
flow seems to lack sufficient accuracy to aid the access
monitoring process (23,24). Access blood flow appears
to have varying degrees of combined sensitivity and
specificity in predicting access thrombosis in an
analysis comparing several studies (23). While it is
clear that there may be many patient- and population-
dependent variables that influence access thrombosis
in addition to access blood flow, the influence of the
follow-up time period from the flow measurement has
not been systematically studied.
We used the variable flow (VF) Doppler method
(19–22) to determine access flow. We used ROC
analysis, comparing areas under the receiver operator
characteristic (ROC) curve, to investigate the effect of
duration of follow-up time from a single access flow
measurement in determining the risk of subsequent
thrombosis. In ROC curve analysis, a test with an
area under the curve (AUC) of 0.5 does not
discriminate between patients who will have an event
and those who will not. An AUC of 1.0 represents a
test that perfectly discriminates between those who will
have an event and those who will not (23).
In addition to comparing the AUC for different
ROC curves across the entire range of observed blood
flow rates, the effect of follow-up time duration on a
surveillance threshold (600 ml/min) in predicting
thrombosis was also evaluated. This was done by
determining the sensitivity and specificity of a flow
measurement less than 600 ml/min to predict access
thrombosis for follow-up intervals ranging from 15 to
180 days.
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studies (19,21,22). Briefly, the dialysis pump induced
change in the Doppler signal between the needles is used
to determine the access blood flow without the need for
cross-sectional area measurement or duplex imaging.
The Doppler transducer is placed between the needles
and the Doppler signal is measured as a function of
dialysis blood pump speed.A linear regression algorithm
is used to determine access flow from these measure-
ments. A spectral Doppler PC board and software
(SPECS USA, Sarasota, FL), which allow calculation
and export of various spectral waveform parameters,
including the instantaneous mean and time-averaged
mean Doppler signals was connected to a laptop
computer for signal analysis and access flow determin-
ation.
Patients
A retrospective record review of 36 patients with
prosthetic bridge grafts was conducted at the Univer-
sity of Michigan Medical Center’s Outpatient Hemo-
dialysis Facility after Investigational Review Board
approval at our institution. All patients who had a VF
Doppler measurement and who consented to medical
record review (36 of 39) were included in the analysis
for the 6-month period starting August 1, 2000. In
order to avoid potential selection bias, an access
thrombosis was defined as the event and not stenosis
without thrombosis. Patients who underwent angiog-
raphy with or without angioplasty at the discretion of
their primary nephrologist were included in the study.
For patients who had multiple VF Doppler measure-
ments, the first measurement after August 1, 2000, was
used. Patients were followed for up to 180 days or
until their first access thrombosis (event) within the
study time period, or until lost from our dialysis unit
(e.g., transplant, death, relocation). Patients were
dialyzed with Fresenius 2008H (Fresenius Medical
Care, Lexington, MA) and Cobe Century System
3 (Gambro Renal Care Products, Lakewood, CO)
with 15-gauge dialysis needles.
Data Analysis
Thenumber of events (thromboses) was determined at
15, 30, 60, 90, 120, 150, and 180 days from the first VF
Doppler measurement in the study interval. The ROC
curves were determined across the range of access blood
flow rates for eachof these follow-up intervals. TheAUC
was determined for each ROC curve. The p-value
represents the probability that an AUC different from
the null hypothesis (AUC of 0.5) may have occurred by
random chance. The sensitivity and specificity were then
determined at each follow-up interval for thromboses
occurring below the suggested threshold access flow
value of 600 ml/min. Values were calculated using SPSS
software (SPSS forWindows, Release 10.0.5; SPSS Inc.,
Chicago, IL).
Results
Follow-up time frommeasurement in days, number of
patients with thromboses, total number (n) of patients
followed until that time interval, and thrombosis rates,
along with the AUC for the ROC curve and p-value for
the AUC are shown in Table 1. The AUC increased as
follow-up time decreased for all follow-up time intervals
in the ROC analysis, indicating improved test discrim-
ination for shorter time intervals. The p-value became
significant (p < 0.05) at 3 and 2 months, but increased
again at the shortest time intervals (15 and 30 days), since
the number of events in this cohort at shorter time
intervals were few.
Combined sensitivity and 1 ) specificity are shown in
the form of ROC curves in Fig. 1 for 60 days follow-up
time (the greatest AUC that maintained a p-value less
than 0.05) compared with 180 days (the longest follow-
up time interval studied). Fig. 2 shows the sensitivity and
specificity for a commonly used access flow value of 600
ml/min as a function of the different follow-up time
intervals (third-order polynomial curve fitted to data
points). Results evaluating the effect of time on the
sensitivity and specificity for this commonly used

















Fig. 1. ROC curves for 60 and 80 days.






rate (%) AUC p
15 1 36 2.78 1.00 0.09
30 3 36 8.33 0.83 0.06
60 4 36 11.11 0.82 0.04
90 7 35 20.00 0.79 0.02
120 8 35 22.86 0.71 0.08
150 8 33 24.24 0.70 0.10
180 14 29 48.28 0.60 0.38
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changed (88% to 93%) for follow-up time intervals from
15 days to 6 months. However, using this threshold
value, sensitivitywas low (21%)at 6months, increased to
50%at 2months, 67% at 1month, and 100% at 15 days
(a single event).
Discussion
The results of this analysis need to be considered
conceptually in the context of the likely relationship
between access flow and thrombosis. Low access flow
likely results frommany factors. Venous outflow stenosis
is commonly thought to be the major entity responsible
for low flow and increased thrombosis risk. However,
access flow is variable and likely influenced by other
dynamic anatomic and nonanatomic factors in addition
to a venous outflow stenosis (24,25). Nonetheless, low
flowappears tobe a risk factor for thrombosis (3,6–8,18),
and declining access flow may also predict thrombosis
(26).
A graft thrombosis is associated with a decrease in
graft blood flow from some starting value to zero over
some time interval. When thrombosis occurs with
initially high flow states, a flow reduction occurring over
seconds, minutes, or hours (significantly less than the
time it takes to schedule a corrective procedure) is too
abrupt to permit flow monitoring to help prevent
thrombosis. This may well be the case in the patient
who sleeps on their access arm, or who has other
independent (non-flow-related) risk factors for throm-
bosis.
On the other hand, when reduced access flow declines
over a longer period of time, then it may be useful in
predicting thrombosis. These data suggest that access
flow may contribute to the prediction of thrombosis for
up to several months; however, it is increasingly
predictive as the follow-up time from the measurement
decreases. In other words, low access flow is most
predictive of thosewhowill clot in the near future but not
the distant future.
Given the high incidence of graft thrombosis with
its high morbidity and cost (1,2,5), it is important to
optimize sensitivity while maintaining specificity for
surveillance programs. An important finding is that
while specificity remained little changed from 15 to
180 days, the sensitivity showed a marked increase as
the follow-up interval was shortened. It may also be
that access flow can contribute to risk assessment for
thrombosis over longer time intervals; however, this
will likely require its use in conjunction with other
comorbidities that may aid in the assessment of
longer-term risk of thrombosis. These data may partly
explain why some studies have failed to show
adequate risk stratification using access flow alone
(24) and why others have indicated that a decrease in
flow heralds thrombosis (26).
In addition, since factors independent of flow may
affect the risk of thrombosis, it is likely that different
patient populations require monitoring at different
intervals in order to achieve desirable sensitivity and
specificity. There may be some groups where access
flow monitoring is not helpful. Most nephrologists
have encountered patients who thrombose repeatedly
despite correcting structural abnormalities and main-
taining adequate access flow. At the other extreme,
patients with grafts who have not thrombosed in years
and yet maintain a relatively low access flow may be
at lower risk of thrombosis for reasons that are not
yet clear. While access flow monitoring may be helpful
for this latter group to ensure they receive adequate
dialysis, caution must be used to avoid unnecessary
procedures for these patients. A better understanding
of non-flow-related risk factors for thrombosis is also
needed in order to use flow optimally as a monitoring
tool.
In conclusion, the discriminative value of access flow
monitoring appears to be highly dependent on time from
the flow measurement. Low flow predicts near-term
thrombosismuch better than long-term thrombosis. The
monitoring interval should be carefully evaluated in
different patient populations in order to establish
rational access surveillance protocols.
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Erratum
Roberta Braun Curtin, Bryan Becker, Paul L. Kimmel, and Dori Schatell: An Integrated Approach to Care for
Patients with Chronic Kidney Disease. Semin Dial 2003;16:399–402.
Due to an inadvertent oversight the abstractwas publishedwith a contextual error. ThePublisher regrets the error.The
following is the corrected abstract.
Although the Kidney Disease Outcomes and Quality Initiative (K/DOQI) guidelines serve to integrate the multiple
stages of chronic kidney disease (CKD), in practice, the treatment of kidney disease over its progressive course may be
somewhat fragmented. Because the provision of integrated care across the stages of kidney disease is likely to be
advantageous for bothpatients and care providers, a conceptual frameworkwhich graphically depicts the complex and
chronic nature of kidney disease may prove useful. The Life Options Rehabilitation Advisory Council (LORAC)
proposes a cycle diagram to reflect the chronicity and complexity of kidney disease and to emphasize a holistic
perceptionof kidneydisease from its inception to theworst-case scenario outcomeof kidney failure.Thekidneydisease
cycle conceptualization can serve as a patient teaching aid and as a reminder of the communication, collaboration, and
cooperation that are required among primary care physicians and practitioners in each of the specialty areas that
address the spectrum of kidney disease.
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